The FDA has approved Rasonque (daraxonrasib) to treat adults with advanced pancreatic cancer. The drug is for people with pancreatic adenocarcinoma that has spread to other parts of the body. It is used when patients… Read more
The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, a rare autoimmune disease. It causes the body’s immune system to attack its own muscles and skin. People with this condition often suffer from… Read more
What Is Ziihera and How Does It Work? The FDA has approved Ziihera (zanidatamab-hrii) to treat adults with advanced or spreading gastroesophageal adenocarcinoma (GEA). GEA includes cancers of the stomach, the esophagus, and the area… Read more
What Is Imaavy and How Does It Work? The FDA has approved Imaavy (nipocalimab-aahu) to treat adults and children 12 and older who have warm autoimmune hemolytic anemia (wAIHA). It is for people who are… Read more
The FDA has approved Rasonque (daraxonrasib) to treat adults with advanced pancreatic cancer. The drug is for people with pancreatic adenocarcinoma that has spread to other parts of the body. It is used when patients… Read more
What Is Lisraya and How Does It Work? The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, a rare autoimmune disease. It causes the body’s immune system to attack its own muscles and… Read more
What Is Bixlenvo and Why Does It Matter? The FDA has approved Bixlenvo for adults with HIV-1. It is meant for adults whose virus is already under control with their current HIV treatment. This means… Read more
What Is Mounjaro and Why Does It Matter? The FDA has expanded the use of Mounjaro (tirzepatide). It is now approved to lower the risk of major heart problems, including heart attacks, strokes, and death… Read more
What Is Mimrylo and How Does It Work? The FDA approved Mimrylo (rusfertide) to treat adults with polycythemia vera who have high red blood cell counts. Polycythemia vera is a rare blood cancer that causes… Read more
What Is Besremi, and Why Does It Matter? Besremi (ropeginterferon alfa-2b) is now FDA-approved to treat adults with a rare blood disorder called essential thrombocythemia. Before this approval, this medicine was already available for adults… Read more